Advised NongHyup Financial Group on its minority investment through NH Capital Co. Ltd. in IFFCO Kisan Finance Limited
NongHyup Financial Group, through its subsidiary NH Capital Co. Ltd. (NH Capital), made a strategic minority equity investment in IFFCO Kisan Finance Limited (IFFCO Kisan), a non-banking financial company in India. This investment aimed to strengthen NongHyup...
Advised Sloki Technologies Private Limited on a strategic investment by Technopro, Japan
Sloki Technologies Private Limited (Sloki), a prominent player in the technology sector, received a strategic investment from Technopro, Japan. Majmudar & Partners played a pivotal role in facilitating this cross-border investment, providing comprehensive legal...
Counselled Punjab National Bank on enforcement of terms of a loan facility against a corporate debtor and its guarantors
Punjab National Bank (“PNB”), one of India’s leading financial institutions, sought legal assistance to address issues surrounding the enforceability of loan and security documents against a corporate debtor in default and its guarantors. Majmudar & Partners...
Advised Hongkong and Shanghai Banking Corporation Limited on a dispute relating to dishonour of loan repayment cheques
The Hongkong and Shanghai Banking Corporation Limited (“HSBC”), one of the world’s leading international banks, engaged Majmudar & Partners to address a dispute involving the dishonour of cheques tendered for repayment of liabilities under credit facilities....
Assisted Clariant Chemicals (India) Limited with the recovery of retrospective service tax from a pharmaceutical company
Clariant Chemicals (India) Limited (“Clariant”), a prominent player in the specialty chemicals industry, sought to recover service tax reimbursement from another leading pharmaceutical company. This claim arose after the Indian government introduced a retrospective...
Assisted Wockhardt Limited in a dispute relating to the cancellation of its license for manufacturing and distribution of drugs
Wockhardt Limited (“Wockhardt”), a global pharmaceutical and biotechnology company, faced a significant dispute concerning the cancellation of its license to manufacture and distribute drugs in India. Majmudar & Partners provided strategic legal representation to...